Physician profile
John T Grigg
NPI 1265438352
$5,704.53
in general payments reported to CMS, 2019-2025
17 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,379 · 2020: $402 · 2021: $456 · 2022: $508 · 2023: $1,811 · 2024: $626 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,959.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,727.04 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $1,351.29 | 2019-2023 | Xarelto |
| Glaxosmithkline, LLC. | $1,287.09 | 2019-2023 | Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $496.84 | 2021-2024 | |
| Novo Nordisk INC | $228.71 | 2019-2022 | |
| Pfizer INC. | $127.14 | 2019-2025 | |
| Amgen INC. | $124.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.81 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $51.32 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.53 | 2022 | |
| Circassia INC. | $33.04 | 2019 | |
| Exact Sciences Corporation | $23.94 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $20.96 | 2021 | |
| Intra-Sana Laboratories | $20.11 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Radius Health, INC. | $18.58 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.37 | 2023 | Mounjaro |
| Aytu Biopharma, INC. | $14.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Grigg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.